Genital Diseases, Male
19
4
5
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
15.8%
3 terminated out of 19 trials
70.0%
-16.5% vs benchmark
21%
4 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (19)
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease
Health Gatherings - For Your Health After Cancer
PRP for Treatment of Peyronie's Disease
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Testosterone Plus Finasteride Treatment After Spinal Cord Injury
Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA
Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma
Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
LANDA Embryo Freezing Technique.
Male Circumcision for HIV Prevention in Rakai, Uganda